Bangladesh vs Eritrea: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Bangladesh
0.4%
in 2024
Eritrea
0.5%
in 2024
Bangladesh rank
59th
Eritrea rank
56th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Bangladesh
- Eritrea
How they compare
Eritrea currently reports 0.5% against 0.4% in Bangladesh, a difference of 0.1%.
That makes Eritrea's figure about 1.2 times Bangladesh's.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Eritrea ahead.
Bangladesh ranks 59th and Eritrea ranks 56th of 215 countries.
Across the 2 decades both report, Bangladesh averaged higher in 1 and Eritrea in 1.
Head to head by decade
| Decade | Bangladesh | Eritrea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.7% | 0.6% | 0.0% | Bangladesh |
| 2020s | 0.5% | 0.6% | 0.1% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Bangladesh or Eritrea?
- Eritrea, at 0.5% against 0.4% in Bangladesh as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Bangladesh and Eritrea?
- 0.1%, with Eritrea ahead.
- How many years of comparable data are there for Bangladesh and Eritrea?
- 10 years are reported by both, from 2015 to 2024.
- How do Bangladesh and Eritrea rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Bangladesh ranks 59th and Eritrea ranks 56th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.